Pharmacodynamic Evaluation of Zoliflodacin Treatment of Neisseria gonorrhoeae Strains With Amino Acid Substitutions in the Zoliflodacin Target GyrB Using a Dynamic Hollow Fiber Infection Model

Novel antimicrobials for effective treatment of uncomplicated gonorrhea are essential, and the first-in-class, oral spiropyrimidinetrione DNA gyrase B inhibitor zoliflodacin appears promising. Using our newly developed Hollow Fiber Infection Model (HFIM), the pharmacodynamics of zoliflodacin was exa...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Frontiers in pharmacology Ročník 13; s. 874176
Hlavní autori:	Jacobsson, Susanne, Golparian, Daniel, Oxelbark, Joakim, Franceschi, Francois, Brown, David, Louie, Arnold, Drusano, George, Unemo, Magnus
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	Switzerland Frontiers Media S.A 14.04.2022
Predmet:	antimicrobial treatment gyrB hollow fiber infection model mutant Neisseria gonorrhoeae pharmacodynamics pharmacokinetics Pharmacology zoliflodacin gyrB Neisseria gonorrhoeae zoliflodacin pharmacodynamics pharmacokinetics hollow fiber infection model mutant antimicrobial treatment
ISSN:	1663-9812, 1663-9812
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!